We are actively seeking partnering opportunities, and collaborations with pharmaceutical and biotechnology companies to develop and commercialize our technologies
Our company is focused on the discovery of novel PTP inhibitors and harnessing their therapeutic potential

Our IND approved lead compound is ready for phase I testing against multiple cancer
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.